HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul A Bunn Selected Research

Combination Drug Therapy (Combination Chemotherapy)

3/2016Neoadjuvant combination chemotherapy for unresectable stage III non-small cell lung cancer.
8/2005Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul A Bunn Research Topics

Disease

88Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2023 - 02/2002
68Lung Neoplasms (Lung Cancer)
02/2024 - 02/2002
61Neoplasms (Cancer)
11/2023 - 02/2002
11Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2024 - 04/2002
6Neoplasm Metastasis (Metastasis)
11/2023 - 03/2002
6Adenocarcinoma of Lung
01/2023 - 02/2015
6Disease Progression
01/2022 - 12/2003
6Adenocarcinoma
01/2018 - 02/2002
5Neutropenia
04/2024 - 05/2004
4Brain Neoplasms (Brain Tumor)
02/2024 - 12/2013
4Febrile Neutropenia
05/2023 - 05/2004
4Breast Neoplasms (Breast Cancer)
01/2018 - 02/2002
3Infections
11/2023 - 05/2004
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2012 - 02/2002
3Prostatic Neoplasms (Prostate Cancer)
08/2005 - 04/2002
2Diarrhea
04/2024 - 06/2002
2Fever (Fevers)
05/2023 - 05/2004
2Alopecia (Baldness)
05/2023 - 05/2004
2Sarcoma (Soft Tissue Sarcoma)
02/2015 - 09/2012
2Chronic Obstructive Pulmonary Disease (COPD)
11/2007 - 05/2006
2Carcinoma (Carcinomatosis)
01/2007 - 07/2002
2Carcinogenesis
12/2005 - 06/2002
2Bronchiolo-Alveolar Adenocarcinoma (Adenocarcinoma, Bronchiolo Alveolar)
10/2005 - 10/2003
2Mesothelioma
06/2002 - 04/2002
1Leukopenia
04/2024
1Anemia
04/2024
1Aneuploidy (Aneuploid)
10/2023
1Central Nervous System Diseases (CNS Diseases)
01/2023
1COVID-19
01/2022
1Intestinal Volvulus (Volvulus)
01/2020

Drug/Important Bio-Agent (IBA)

38ErbB Receptors (EGF Receptor)IBA
01/2023 - 02/2002
27Tyrosine Kinase InhibitorsIBA
02/2024 - 02/2002
18Gefitinib (Iressa)FDA Link
01/2018 - 02/2002
15Biomarkers (Surrogate Marker)IBA
01/2018 - 07/2002
13Proteins (Proteins, Gene)FDA Link
10/2020 - 02/2002
11Docetaxel (Taxotere)FDA Link
05/2023 - 02/2002
11Pemetrexed (MTA)FDA Link
05/2023 - 04/2002
11Cisplatin (Platino)FDA LinkGeneric
01/2018 - 04/2002
9Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2017 - 12/2006
8Carboplatin (JM8)FDA LinkGeneric
01/2018 - 04/2002
6CrizotinibIBA
11/2018 - 12/2012
5Irinotecan (Camptosar)FDA LinkGeneric
04/2024 - 11/2002
5Monoclonal AntibodiesIBA
01/2018 - 02/2002
5Paclitaxel (Taxol)FDA LinkGeneric
09/2011 - 01/2003
5sulindac sulfone (exisulind)IBA
10/2007 - 02/2002
5GemcitabineFDA Link
11/2005 - 04/2002
4atezolizumabIBA
12/2023 - 10/2022
4Etoposide (VP 16)FDA LinkGeneric
11/2023 - 05/2006
4DNA (Deoxyribonucleic Acid)IBA
10/2023 - 06/2002
4Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
05/2006 - 02/2002
3PlatinumIBA
11/2023 - 10/2007
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2020 - 12/2006
3Phosphotransferases (Kinase)IBA
01/2018 - 01/2013
3human ERBB2 proteinIBA
11/2017 - 02/2015
3Anaplastic Lymphoma KinaseIBA
03/2016 - 09/2012
3Messenger RNA (mRNA)IBA
06/2014 - 05/2006
3Cetuximab (Erbitux)FDA Link
07/2008 - 01/2005
3Bradykinin Receptor AntagonistsIBA
08/2005 - 05/2002
3Trastuzumab (Herceptin)FDA Link
06/2002 - 02/2002
2Topotecan (Hycamtin)FDA LinkGeneric
04/2024 - 11/2017
2AntibodiesIBA
11/2023 - 03/2008
2Immune Checkpoint InhibitorsIBA
10/2023 - 01/2023
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2023 - 05/2004
2Formaldehyde (Formol)FDA Link
10/2020 - 02/2013
2osimertinibIBA
01/2020 - 03/2017
2KIR ReceptorsIBA
01/2018 - 12/2016
2taxaneIBA
01/2018 - 03/2002
2TankyrasesIBA
03/2017 - 08/2012
2Volatile Organic CompoundsIBA
08/2013 - 07/2012
2GoldIBA
08/2013 - 07/2012
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2013 - 01/2004
2Epoprostenol (Prostacyclin)FDA LinkGeneric
02/2013 - 06/2011
2Bevacizumab (Avastin)FDA Link
01/2013 - 03/2007
2Epidermal Growth Factor (EGF)IBA
01/2009 - 05/2005
2Cadherins (E-Cadherin)IBA
06/2007 - 01/2006
2Metalloproteases (Metalloproteinases)IBA
08/2005 - 12/2002
2Cyclic GMPIBA
05/2003 - 03/2002
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
05/2003 - 03/2002
2BradykininIBA
12/2002 - 04/2002
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2002 - 04/2002
2Drug CombinationsIBA
09/2002 - 06/2002
2AntimetabolitesIBA
06/2002 - 04/2002
2NeuropeptidesIBA
05/2002 - 04/2002
2Antineoplastic Agents (Antineoplastics)IBA
05/2002 - 02/2002
2EnzymesIBA
05/2002 - 03/2002
1Hematoxylin (Haematoxylon)IBA
10/2023
1Eosine Yellowish-(YS) (Eosin)IBA
10/2023
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2023
1VaccinesIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1ParaffinIBA
10/2020

Therapy/Procedure

55Therapeutics
02/2024 - 04/2002
22Drug Therapy (Chemotherapy)
11/2023 - 02/2002
9Chemoprevention
10/2019 - 02/2002
6Radiotherapy
01/2023 - 09/2004
4Neoadjuvant Therapy
10/2023 - 12/2018
3Adjuvant Chemotherapy
06/2007 - 09/2004
2Immunotherapy
12/2018 - 01/2016
2Combination Drug Therapy (Combination Chemotherapy)
03/2016 - 08/2005
2Aftercare (After-Treatment)
06/2007 - 05/2003